New plan boosts Denmark’s Pfizer vaccine deliveries
Pharma company Pfizer has revised its plan for deliveries of its Covid-19 vaccine to Denmark in the coming months.
The plan has been updated after the company reached a deal with the European Union to expedite deliveries of its vaccine which had been scheduled for later in 2021.
Pfizer/BioNTech now expects to deliver an extra 700,000 doses of its vaccine to Denmark in the second quarter of this year. The figure was confirmed by the Danish national infectious disease agency State Serum Institute (SSI) via its website.
The week beginning Monday April 26th will see at least 270,000 doses of the company’s vaccine delivered to Denmark on a weekly basis. That will further increase from May 31st, with between 388,440 and 389,610 doses arriving each week for the five weeks following on from that date.
The numbers are stated on a summary available on the SSI website.
News of the extra doses was welcomed by the agency’s deputy director Ole Jensen.
“In a situation in which the AstraZeneca vaccine will be playing a smaller role in the vaccination of the Danish public it is very positive that Pfizer can push forward deliveries which we should have had later in the year,” Jensen said in a written comment.
Denmark confirmed earlier this week it will withdraw the AstraZeneca vaccine from the country's Covid-19 vaccination programme.
The Nordic country said on Tuesday it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
READ ALSO: Denmark withdraws AstraZeneca from Covid-19 vaccination programme
On Wednesday, the EU it would get 50 million Pfizer vaccine doses earlier than expected.
That was initially reported as giving an additional 650,000 doses of the Pfizer vaccine to be sent to Denmark in the second quarter of 2021.
But the latest update from SSI suggests the figure will actually be 700,000. The new plan for weekly deliveries was published on Friday.
Comments
See Also
The plan has been updated after the company reached a deal with the European Union to expedite deliveries of its vaccine which had been scheduled for later in 2021.
Pfizer/BioNTech now expects to deliver an extra 700,000 doses of its vaccine to Denmark in the second quarter of this year. The figure was confirmed by the Danish national infectious disease agency State Serum Institute (SSI) via its website.
The week beginning Monday April 26th will see at least 270,000 doses of the company’s vaccine delivered to Denmark on a weekly basis. That will further increase from May 31st, with between 388,440 and 389,610 doses arriving each week for the five weeks following on from that date.
The numbers are stated on a summary available on the SSI website.
News of the extra doses was welcomed by the agency’s deputy director Ole Jensen.
“In a situation in which the AstraZeneca vaccine will be playing a smaller role in the vaccination of the Danish public it is very positive that Pfizer can push forward deliveries which we should have had later in the year,” Jensen said in a written comment.
Denmark confirmed earlier this week it will withdraw the AstraZeneca vaccine from the country's Covid-19 vaccination programme.
The Nordic country said on Tuesday it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
READ ALSO: Denmark withdraws AstraZeneca from Covid-19 vaccination programme
On Wednesday, the EU it would get 50 million Pfizer vaccine doses earlier than expected.
That was initially reported as giving an additional 650,000 doses of the Pfizer vaccine to be sent to Denmark in the second quarter of 2021.
But the latest update from SSI suggests the figure will actually be 700,000. The new plan for weekly deliveries was published on Friday.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.